Skip to main content
UniHealth

Doctor search

Thomas T Chen, MD

Medical Oncology · Stanford

NPI 1891870317

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
17
3 carriers
Office
1
Since medical school
30 years
Stanford University School of Medicine, 1996

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: El Camino Health · Good Samaritan Hospital · Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

17 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chen’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

17 of 17 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence G84369 · Current

Licensed to practise in California · since 1998 · expires 2028-01-31 · Stanford University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Internal Medicine - Internal Medicine
  • American Board of Internal Medicine - Medical Oncology

Hospitals they work in

3 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend it
    Overall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
  • Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend it
    Overall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health

Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at El Camino Health
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.291BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.393BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.96 (0.12 to 1.79) · 2,340 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.02 (0.76 to 1.28)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths167.38 (125.03 to 209.73) · 96 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.6 · 68 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.1 · 185 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11.8 · 200 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths8.9 · 814 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths13 · 842 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.6 · 361 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.6 · 4,633 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.34) · 11,474 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.27 (0.1 to 0.45) · 11,626 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.14 (1.39 to 4.9) · 2,814 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths2 (0.61 to 3.39) · 1,327 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.11 (0.8 to 3.43) · 2,641 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths9.39 (4.18 to 14.6) · 1,287 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths6.57 (3.47 to 9.68) · 1,308 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths2.14 (0.71 to 3.57) · 827 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.6 (0.05 to 1.15) · 9,460 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.5 · 122 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.993No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.706No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.376No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.5 · 218 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.5 · 962 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits3.8 · 200 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-17 · 922 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits18.6 · 860 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits18.7 · 827 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.1 (4.5 to 8.2) · 313 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits13.4 (10.6 to 16.5) · 313 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6.1 · 144 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.7 · 237 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.8 (10 to 16.1) · 1,639 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.8 to 1.1) · 1,619 casesNo differentJan 2024 – Dec 2024

What patients said (1,535 patients answered, 22% of those asked)

Patient survey stars by topic at El Camino Health
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information3
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at El Camino Health
Room was "always" clean75%
Nurses "always" communicated well79%
Doctors "always" communicated well81%
Staff "always" explained61%
Yes, staff "did" give patients this information86%
Yes, staff "did" give patients information about help after discharge86%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)76%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand75%
Nurses "always" listened carefully76%
Nurses "always" treated them with courtesy and respect87%
"Always" quiet at night47%
"YES", patients would definitely recommend the hospital80%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms86%
See every measure and the patient survey for Good Samaritan Hospital

Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Good Samaritan Hospital
Clostridium Difficile (C.Diff)Infections0.337BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.75 (0 to 1.67) · 1,340 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.84 (0.54 to 1.14)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths143.59 (98.7 to 188.49) · 98 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.7 · 45 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.1 · 100 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.7 · 270 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths11.3 · 573 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths15.6 · 820 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.5 · 482 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.3 · 3,711 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.12 (0 to 0.3) · 8,866 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.2 (0.01 to 0.38) · 9,051 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths2.65 (0.74 to 4.56) · 1,929 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.8 (0.21 to 3.39) · 670 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.33 (0.88 to 3.78) · 1,836 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths6.73 (0 to 13.46) · 669 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths7.58 (3.96 to 11.19) · 654 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.59 (0.13 to 3.04) · 496 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.27 (0 to 0.87) · 7,373 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.1 · 152 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections1.08No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.542No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.484No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.565No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.8 · 327 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits24.2 · 703 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits61.1 · 289 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits36.3 · 665 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits25.4 · 856 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits19 · 978 casesNoneJul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits6.3 · 144 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits12.3 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits21.2 · 135 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.8 (10.1 to 18.6) · 129 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.2 (0.9 to 1.5) · 531 casesNo differentJan 2024 – Dec 2024

What patients said (704 patients answered, 24% of those asked)

Patient survey stars by topic at Good Samaritan Hospital
Cleanliness3
Nurse communication3
Doctor communication2
Communication about medicines2
Discharge information3
Overall hospital rating2
Quietness1
Recommend hospital3
Share of patients giving the best answer at Good Samaritan Hospital
Room was "always" clean66%
Nurses "always" communicated well75%
Doctors "always" communicated well71%
Staff "always" explained54%
Yes, staff "did" give patients this information83%
Yes, staff "did" give patients information about help after discharge81%
Doctors "always" explained things so they could understand66%
Doctors "always" listened carefully69%
Doctors "always" treated them with courtesy and respect78%
Patients who gave a rating of "9" or "10" (high)63%
Staff "always" explained new medications68%
Nurses "always" explained things so they could understand69%
Nurses "always" listened carefully73%
Nurses "always" treated them with courtesy and respect82%
"Always" quiet at night38%
"YES", patients would definitely recommend the hospital67%
Staff "always" explained possible side effects40%
Yes, staff "did" give patients information about possible symptoms86%
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$228,581

Medicare paid this office $228,581 for 620 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)283$102,595$129
Return visit (30+ min)374$56,743$84
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes91$23,505$106
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's430$18,450$15
New patient visit (60+ min)87$13,074$150
See all 8 services
Every Original Medicare service billed
Long return visit (40+ min)283$102,595$129
Return visit (30+ min)374$56,743$84
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes91$23,505$106
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's430$18,450$15
New patient visit (60+ min)87$13,074$150
Initial hospital care with moderate level of medical decision making at least 75 minutes46$6,973$152
Short return visit (20+ min)46$3,485$63
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes22$1,832$70

Who their Medicare patients are

620 Original Medicare patients in 2024. Average age 78 · Under 65 3% · 85 and older 22% · Women 52% · Also on Medicaid 17% · Health risk score 2.07. At or below the middle of the specialty; the typical medical oncology clinician is at 2.11.

Conditions among them: High blood pressure 75% · Cancer 42% · Diabetes 37% · Coronary heart disease 35% · Chronic kidney disease 30% · Atrial fibrillation 29% · Heart failure 24% · Depression 19% · COPD 15% · Stroke 12% · Dementia 11%.

The office billed $659,118, Medicare allowed $302,515 and paid $228,581; for 3,200 services of 11 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20246203,200782.07$659,118$228,581
20235931,742771.99$428,444$175,019
20226312,008772.00$541,721$201,536
20216061,893761.98$561,085$194,684
20205451,825762.03$489,563$144,824
20195131,920761.87$243,476$142,077
20185031,861761.92$234,530$129,151
20175361,957761.96$355,527$131,344
20165442,163761.82$394,424$127,359
201555360,068761.81$3,696,401$859,381
201456568,301761.86$5,440,968$1,237,758
201361865,176761.78$4,789,767$1,305,120

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 7 services

Original Medicare services billed in 2023
Long return visit (40+ min)254$75,844$122
Return visit (30+ min)394$58,836$80
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes63$16,079$107
New patient visit (60+ min)91$13,786$151
Initial hospital care with moderate level of medical decision making at least 75 minutes21$3,282$156
Short return visit (20+ min)52$3,208$47
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes27$2,923$71

2022: 7 services

Original Medicare services billed in 2022
Long return visit (40+ min)286$94,395$120
Return visit (30+ min)363$54,288$80
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes89$22,834$91
New patient visit (60+ min)99$15,361$155
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes54$5,696$60
Initial hospital care with moderate level of medical decision making at least 75 minutes21$3,754$179
Short return visit (20+ min)54$3,736$56

2021: 8 services

Original Medicare services billed in 2021
Long return visit (40+ min)299$101,888$122
Return visit (30+ min)306$41,869$82
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes90$17,374$96
New patient visit (60+ min)78$13,583$174
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes61$8,100$67
Short return visit (20+ min)90$5,854$46
Initial hospital care with moderate level of medical decision making at least 75 minutes24$4,441$185
New patient visit (45+ min)11$1,191$108

2020: 9 services

Original Medicare services billed in 2020
Return visit (30+ min)331$49,867$66
Long return visit (40+ min)181$46,934$101
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes63$12,947$97
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes66$10,716$67
New patient visit (60+ min)63$9,114$145
Short return visit (20+ min)102$6,169$39
Initial hospital care with moderate level of medical decision making at least 75 minutes26$5,127$190
New patient visit (45+ min)20$2,209$110
Telehealth originating site facility fee13$250$19

2019: 8 services

Original Medicare services billed in 2019
Return visit (30+ min)333$63,378$66
Long return visit (40+ min)167$42,191$96
Short return visit (20+ min)133$9,399$39
New patient visit (60+ min)58$8,228$142
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes43$6,535$66
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes41$6,131$94
Initial hospital care with moderate level of medical decision making at least 75 minutes16$3,120$184
New patient visit (45+ min)18$2,013$112

2018: 7 services

Original Medicare services billed in 2018
Return visit (30+ min)350$66,160$64
Long return visit (40+ min)133$27,343$93
Short return visit (20+ min)134$9,145$39
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes57$7,793$64
New patient visit (60+ min)45$6,347$141
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes35$6,179$91
New patient visit (45+ min)25$2,767$111

2017: 10 services

Original Medicare services billed in 2017
Return visit (30+ min)327$56,603$66
Long return visit (40+ min)128$25,205$98
Short return visit (20+ min)241$16,898$37
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes62$11,227$65
New patient visit (60+ min)65$8,958$138
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes39$6,200$91
Initial hospital care with moderate level of medical decision making at least 75 minutes12$2,175$181
New patient visit (45+ min)13$1,368$105
Biopsy of bone marrow13$968$69
Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service12$105$8

2016: 11 services

Original Medicare services billed in 2016
Short return visit (20+ min)403$45,079$40
Return visit (30+ min)231$31,205$67
Long return visit (40+ min)113$18,383$97
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes65$10,417$64
New patient visit (60+ min)57$8,321$146
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes33$4,444$93
Initial hospital care with moderate level of medical decision making at least 75 minutes21$3,785$180
New patient visit (45+ min)23$2,425$105
New patient visit (30+ min)21$1,095$52
Biopsy of bone marrow13$897$69
Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service13$104$8

2015: 26 services

Original Medicare services billed in 2015
Injection, rituximab, 100 mg12$142,962None
Injection, epoetin alfa, (for non-esrd use), 1000 units23$48,908None
Short return visit (20+ min)348$47,924$60
Short return visit (20+ min)334$28,892$45
Administration of chemotherapy into vein, 1 hour or less33$16,731$138
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes69$12,008$64
Injection of drug or substance under skin or into muscle49$6,520$25
Return visit (30+ min)54$6,054$70
Return visit (30+ min)45$5,427$90
New patient visit (60+ min)31$4,612$149
New patient visit (60+ min)23$4,169$181
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less19$4,006$68
Long return visit (40+ min)33$3,647$99
Long return visit (40+ min)20$3,475$134
Injection, zoledronic acid, 1 mg13$3,245None
Administration of chemotherapy into vein, each additional hour19$2,959$28
Injection of additional new drug or substance into vein26$2,755$23
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes27$2,602$90
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less21$2,592$30
Administration of additional new drug or substance into vein, 1 hour or less12$2,540$64
Initial hospital care with moderate level of medical decision making at least 75 minutes14$2,504$179
Drawing of blood for a medical problem18$2,146$72
Short return visit16$954$41
Injection, granisetron hydrochloride, 100 mcg11$221None
Injection, dexamethasone sodium phosphate, 1 mg12$70None
Injection, diphenhydramine hcl, up to 50 mg14$14None

2014: 34 services

Original Medicare services billed in 2014
Injection, rituximab, 100 mg13$158,719None
Injection, epoetin alfa, (for non-esrd use), 1000 units36$108,678None
Short return visit (20+ min)450$94,719$62
Injection, denosumab, 1 mg11$67,372None
Administration of chemotherapy into vein, 1 hour or less38$20,543$137
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes90$17,439$64
Injection, zoledronic acid, 1 mg17$13,245None
Injection of drug or substance under skin or into muscle74$11,093$24
Return visit (30+ min)75$10,272$95
New patient visit (60+ min)49$8,770$179
Injection, palonosetron hcl, 25 mcg14$7,536None
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less26$6,309$70
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes48$5,915$92
Long return visit (40+ min)32$5,236$128
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less31$4,926$30
Administration of chemotherapy into vein, each additional hour23$4,887$28
Drawing of blood for a medical problem22$4,784$87
Initial hospital care with moderate level of medical decision making at least 75 minutes22$4,317$180
Biopsy of bone marrow20$3,618$164
Injection of additional new drug or substance into vein30$2,933$22
Administration of additional new drug or substance into vein, 1 hour or less12$2,832$63
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle11$1,883$32
Short return visit21$1,162$42
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour11$1,155$18
Administration of influenza virus vaccine40$1,152$29
Infusion into a vein for hydration, 31-60 minutes12$1,043$58
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes17$833$35
Infusion into a vein for hydration, each additional hour19$702$15
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)37$572$15
Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service20$259$12
Injection, dexamethasone sodium phosphate, 1 mg17$140None
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg15$99None
Injection, ranitidine hydrochloride, 25 mg11$81None
Injection, diphenhydramine hcl, up to 50 mg13$23None

2013: 26 services

Original Medicare services billed in 2013
Injection, epoetin alfa, (for non-esrd use), 1000 units44$144,498None
Injection, denosumab, 1 mg17$98,628None
Short return visit (20+ min)472$93,481$61
Injection, zoledronic acid (zometa), 1 mg17$31,815None
Administration of chemotherapy into vein, 1 hour or less31$29,080$147
Injection, palonosetron hcl, 25 mcg24$22,220None
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes105$16,177$62
Return visit (30+ min)101$15,489$92
Injection of drug or substance under skin or into muscle82$14,817$25
Zoldedronic acid 1mg14$14,697$139
New patient visit (60+ min)52$9,464$182
Long return visit (40+ min)54$8,633$129
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less31$7,983$32
Initial hospital care with moderate level of medical decision making at least 75 minutes45$7,911$172
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes52$7,187$89
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less36$6,442$73
Injection of additional new drug or substance into vein33$4,642$23
Drawing of blood for a medical problem22$3,601$49
Infusion into a vein for hydration, each additional hour20$3,137$15
Administration of additional new drug or substance into vein, 1 hour or less11$3,124$73
Administration of chemotherapy into vein, each additional hour14$2,183$31
Administration of influenza virus vaccine44$1,177$27
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)43$617$14
Injection, dexamethasone sodium phosphate, 1 mg25$210None
5% dextrose/normal saline (500 ml = 1 unit)13$61None
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg12$54None

Medicaid work

$4,072 in 2024

Medicaid paid $4,072 for 155 billed services this clinician did in 2024, up to 17 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Long return visit (40+ min)127$3,712
Return visit (30+ min)13$333
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)15$27
Medicaid work by year
2024155317$4,072
2023337224$10,048
2022301220$8,744
2021220225$6,670
202094119$3,226
2019113116$3,429
2018216122$7,571
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Return visit (30+ min)197$5,522
Long return visit (40+ min)140$4,526

2022

Largest Medicaid services in 2022
Long return visit (40+ min)157$5,413
Return visit (30+ min)144$3,331

2021

Largest Medicaid services in 2021
Long return visit (40+ min)159$5,427
Return visit (30+ min)61$1,243

2020

Largest Medicaid services in 2020
Return visit (30+ min)94$3,226

2019

Largest Medicaid services in 2019
Return visit (30+ min)113$3,429

2018

Largest Medicaid services in 2018
Return visit (30+ min)216$7,571

Drugs they prescribed that Part D paid

$2,479,319

Pharmacies billed $2,479,319 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 3% of their Part D prescriptions (30 of 992) in 2024. At or below the middle of the specialty; the typical medical oncology clinician is at 6%.

765 generic and 227 brand-name prescriptions · $2,479,319 in drug cost · 30 antibiotic prescriptions to 20 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Tagrisso25$434,677$17,387
Jakafi17$252,742$14,867
Brukinsa13$112,788$8,676
Eliquis47$33,125$705
Abiraterone Acetate32$13,304$416
See all 21 drugs
Every Part D drug this clinician prescribed
Tagrisso25$434,677$17,387
Jakafi17$252,742$14,867
Brukinsa13$112,788$8,676
Eliquis47$33,125$705
Abiraterone Acetate32$13,304$416
Xarelto14$11,084$792
Imatinib Mesylate33$4,977$151
Hydroxyurea77$1,580$21
Enoxaparin13$1,568$121
Anastrozole38$842$22
Dexamethasone47$817$17
Tamoxifen Citrate14$444$32
Letrozole18$348$19
Prochlorperazine Maleate40$319$8
Prednisone56$317$6
Ondansetron45$268$6
Allopurinol16$233$15
Gabapentin14$232$17
Mirtazapine14$169$12
Alendronate11$121$11
Oxycodone12$96$8

Year by year

Part D prescribing by year
20249921943% (30)23%$2,479,319
20237581796% (43)None$2,499,544
20227691585% (38)None$3,141,281
20219771785% (47)33%$3,854,493
20201,0391997% (76)31%$2,824,567
20191,4832198% (112)29%$3,858,003
20181,7552618% (140)27%$3,873,023
20171,7292608% (146)25%$2,783,714
20161,4332249% (133)None$1,715,410
20151,3472269% (127)None$1,717,417
20141,4391899% (124)None$1,503,484
20131,32619810% (134)None$1,495,963

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 20 drugs

Part D drugs prescribed in 2023
Jakafi21$376,007$17,905
Retevmo12$272,444$22,704
Revlimid13$252,845$19,450
Tagrisso14$239,355$17,097
Calquence11$152,622$13,875
Eliquis45$33,120$736
Abiraterone Acetate27$29,164$1,080
Xarelto18$15,306$850
Hydroxyurea61$2,237$37
Estradiol (Once Weekly)12$854$71
Anastrozole25$817$33
Dexamethasone29$737$25
Prednisone28$377$13
Acyclovir12$369$31
Ondansetron28$368$13
Hydrocodone-Acetaminophen17$334$20
Nystatin11$274$25
Prochlorperazine Maleate16$193$12
Warfarin12$93$8
Allopurinol14$83$6

2022: 22 drugs

Part D drugs prescribed in 2022
Jakafi41$662,297$16,154
Revlimid25$553,844$22,154
Pomalyst27$513,061$19,002
Tagrisso27$446,231$16,527
Nubeqa12$143,542$11,962
Eliquis57$42,619$748
Xarelto24$27,098$1,129
Abiraterone Acetate24$13,111$546
Dexamethasone35$1,131$32
Hydroxyurea29$797$27
Letrozole13$774$60
Estradiol (Once Weekly)11$763$69
Acyclovir11$366$33
Gabapentin15$355$24
Prednisone33$348$11
Ondansetron15$320$21
Amlodipine Besylate11$220$20
Atorvastatin11$211$19
Prochlorperazine Maleate15$163$11
Losartan19$160$8
Temazepam11$31$3
Lisinopril12$8$1

2021: 23 drugs

Part D drugs prescribed in 2021
Pomalyst40$833,870$20,847
Revlimid42$767,839$18,282
Tagrisso38$614,834$16,180
Jakafi31$470,892$15,190
Alecensa11$182,228$16,566
Imbruvica11$141,959$12,905
Abiraterone Acetate42$57,881$1,378
Xarelto41$29,160$711
Eliquis31$20,729$669
Hydroxyurea41$2,567$63
Dexamethasone35$1,088$31
Megestrol Acetate12$796$66
Acyclovir17$542$32
Ondansetron27$522$19
Prednisone47$464$10
Prochlorperazine Maleate26$393$15
Hydrocodone-Acetaminophen16$315$20
Anastrozole25$297$12
Letrozole12$295$25
Oxycodone11$253$23
Mirtazapine13$218$17
Famotidine14$134$10
Pantoprazole11$120$11

2020: 27 drugs

Part D drugs prescribed in 2020
Tagrisso31$495,510$15,984
Pomalyst22$493,157$22,416
Jakafi30$428,116$14,271
Revlimid17$327,984$19,293
Imatinib Mesylate13$53,664$4,128
Xarelto27$13,865$514
Eliquis26$13,850$533
Abiraterone Acetate12$12,042$1,003
Exemestane11$5,122$466
Hydroxyurea35$1,838$53
Dexamethasone20$1,010$50
Prednisone65$894$14
Anastrozole44$830$19
Gabapentin24$705$29
Letrozole28$672$24
Acyclovir21$605$29
Oxycodone14$486$35
Warfarin17$465$27
Morphine Sulfate Er15$456$30
Hydrocodone-Acetaminophen19$405$21
Levothyroxine13$367$28
Mirtazapine16$311$19
Ondansetron13$290$22
Ondansetron Odt12$269$22
Atorvastatin11$167$15
Allopurinol17$139$8
Prochlorperazine Maleate11$133$12

2019: 36 drugs

Part D drugs prescribed in 2019
Tagrisso47$737,935$15,701
Revlimid42$614,962$14,642
Jakafi40$541,987$13,550
Pomalyst24$416,634$17,360
Ibrance25$312,233$12,489
Imatinib Mesylate25$89,947$3,598
Xarelto54$27,790$515
Exemestane26$9,570$368
Eliquis15$9,427$628
Entecavir21$6,191$295
Hydroxyurea69$3,027$44
Anastrozole111$2,158$19
Valacyclovir20$1,563$78
Estradiol16$1,504$94
Coumadin11$1,459$133
Letrozole54$1,237$23
Levothyroxine41$906$22
Oxycodone-Acetaminophen30$901$30
Gabapentin37$821$22
Fentanyl14$749$54
Acyclovir34$720$21
Oxycodone21$594$28
Dexamethasone23$574$25
Prednisone47$560$12
Mirtazapine16$542$34
Warfarin33$523$16
Morphine Sulfate Er13$494$38
Omeprazole16$399$25
Hydrocodone-Acetaminophen21$373$18
Ondansetron21$369$18
Allopurinol15$363$24
Hydroxyzine11$242$22
Zolpidem16$219$14
Prochlorperazine Maleate19$185$10
Lorazepam22$95$4
Diazepam14$67$5

2018: 43 drugs

Part D drugs prescribed in 2018
Pomalyst54$834,644$15,456
Jakafi48$688,265$14,339
Tagrisso29$421,765$14,544
Cabometyx13$229,366$17,644
Xtandi22$215,225$9,783
Zytiga18$180,852$10,047
Imatinib Mesylate28$176,911$6,318
Verzenio13$157,309$12,101
Xarelto61$32,788$538
Entecavir20$23,602$1,180
Exemestane44$13,707$312
Morphine Sulfate16$5,037$315
Hydroxyurea88$4,029$46
Incruse Ellipta11$3,409$310
Anastrozole138$2,825$20
Valacyclovir22$2,175$99
Coumadin13$1,720$132
Estradiol19$1,690$89
Fentanyl23$1,610$70
Hydrocodone-Acetaminophen48$1,426$30
Letrozole76$1,344$18
Tamoxifen Citrate13$855$66
Gabapentin48$704$15
Mirtazapine16$694$43
Levothyroxine23$559$24
Prednisone47$504$11
Oxycodone16$503$31
Allopurinol27$490$18
Warfarin26$458$18
Acyclovir22$420$19
Oxycodone-Acetaminophen19$414$22
Ondansetron25$377$15
Dexamethasone17$377$22
Omeprazole16$296$19
Potassium Chloride20$260$13
Lorazepam40$149$4
Ondansetron Odt11$139$13
Diazepam27$138$5
Zolpidem12$111$9
Mupirocin21$101$5
Prochlorperazine Maleate19$99$5
Losartan14$87$6
Furosemide14$51$4

2017: 43 drugs

Part D drugs prescribed in 2017
Pomalyst47$665,916$14,168
Revlimid43$442,670$10,295
Jakafi34$414,672$12,196
Imatinib Mesylate36$261,605$7,267
Tarceva24$169,288$7,054
Leukeran17$15,739$926
Xarelto37$15,496$419
Exemestane33$13,101$397
Hydroxyurea103$3,845$37
Creon13$3,265$251
Valacyclovir18$2,295$127
Anastrozole88$1,726$20
Fentanyl21$1,664$79
Estradiol18$1,114$62
Clindamycin Phosphate13$1,100$85
Morphine Sulfate Er18$1,025$57
Acyclovir55$999$18
Tamoxifen Citrate11$953$87
Letrozole72$950$13
Gabapentin50$842$17
Hydrocodone-Acetaminophen46$781$17
Hydrocortisone11$607$55
Warfarin32$605$19
Dexamethasone50$601$12
Oxycodone20$541$27
Potassium Chloride14$505$36
Hydroxyzine11$498$45
Prednisone50$493$10
Diphenoxylate-Atropine12$466$39
Ondansetron45$464$10
Omeprazole27$458$17
Oxycodone-Acetaminophen17$348$20
Levothyroxine17$315$19
Pravastatin26$286$11
Allopurinol26$280$11
Levofloxacin13$172$13
Prochlorperazine Maleate23$159$7
Cephalexin15$138$9
Lorazepam33$134$4
Zolpidem13$122$9
Furosemide29$121$4
Pantoprazole13$96$7
Famotidine11$59$5

2016: 38 drugs

Part D drugs prescribed in 2016
Revlimid38$384,068$10,107
Jakafi31$335,508$10,823
Imatinib Mesylate24$170,251$7,094
Pomalyst12$158,096$13,175
Ibrance13$135,642$10,434
Exjade11$85,876$7,807
Exemestane14$4,416$315
Xarelto14$4,166$298
Fentanyl18$3,961$220
Hydroxyurea108$3,511$33
Oxycodone-Acetaminophen25$1,542$62
Hydrocodone-Acetaminophen44$1,460$33
Anastrozole57$883$15
Tamoxifen Citrate24$858$36
Gabapentin49$832$17
Ketoconazole11$782$71
Estradiol11$778$71
Letrozole60$774$13
Voltaren14$697$50
Metoprolol24$564$24
Warfarin39$467$12
Acyclovir28$466$17
Pravastatin27$455$17
Dexamethasone39$436$11
Allopurinol35$421$12
Morphine Sulfate Er20$339$17
Omeprazole22$330$15
Prednisone43$314$7
Tamsulosin19$282$15
Pantoprazole17$229$13
Lorazepam34$180$5
Levothyroxine11$176$16
Mirtazapine11$163$15
Ondansetron13$121$9
Prochlorperazine Maleate14$84$6
Ondansetron Odt11$66$6
Citalopram Hbr12$54$4
Hydrochlorothiazide12$30$2

2015: 39 drugs

Part D drugs prescribed in 2015
RevlimidNone55$529,773$9,632
GleevecNone48$370,116$7,711
PomalystNone20$213,016$10,651
JakafiNone17$163,180$9,599
ThalomidNone12$94,380$7,865
Gamunex-CImmune globulin26$53,090$2,042
Lamivudine HbvNone17$5,845$344
HydroxyureaNone101$3,727$37
FentanylNone18$2,795$155
KetoconazoleNone23$2,793$121
Oxycodone-AcetaminophenNone34$2,126$63
AnastrozoleNone53$1,168$22
Morphine Sulfate ErNone17$1,059$62
LetrozoleNone70$802$11
Hydrocodone-AcetaminophenNone37$744$20
Tamoxifen CitrateNone21$706$34
ValacyclovirNone11$654$59
Potassium ChlorideNone11$558$51
LevothyroxineNone30$436$15
MetoprololNone14$427$31
AcyclovirNone37$408$11
OmeprazoleNone24$361$15
DexamethasoneNone32$354$11
HydrocortisoneNone14$339$24
WarfarinNone21$258$12
LorazepamNone40$244$6
TamsulosinNone13$236$18
GabapentinNone25$218$9
ZolpidemNone20$198$10
PrednisoneNone19$196$10
PravastatinNone11$180$16
AllopurinolNone14$170$12
MupirocinNone11$121$11
AlendronateNone20$118$6
FurosemideNone18$69$4
CiprofloxacinNone11$66$6
Citalopram HbrNone16$62$4
Prochlorperazine MaleateNone11$62$6
MetoprololNone11$43$4

2014: 44 drugs

Part D drugs prescribed in 2014
Gleevec53$339,540$6,406
Pomalyst24$227,141$9,464
Jakafi21$185,071$8,813
Revlimid22$176,434$8,020
Thalomid21$128,544$6,121
Sprycel11$106,715$9,701
Leukeran16$5,755$360
Hydroxyurea87$4,870$56
Duloxetine15$3,848$257
Letrozole42$2,116$50
Anagrelide12$1,967$164
Ketoconazole20$1,903$95
Fentanyl11$1,567$142
Oxycodone-Acetaminophen24$1,378$57
Morphine Sulfate Er17$1,182$70
Tamoxifen Citrate38$1,067$28
Hydrocodone-Acetaminophen58$992$17
Bicalutamide16$989$62
Valacyclovir18$890$49
Zolpidem Tartrate Er12$700$58
Anastrozole26$530$20
Ondansetron27$487$18
Clarithromycin11$484$44
Omeprazole42$481$11
Gabapentin36$461$13
Prednisone45$405$9
Acyclovir24$324$14
Dexamethasone34$302$9
Megestrol Acetate16$258$16
Warfarin15$250$17
Tamsulosin15$210$14
Levothyroxine16$206$13
Amlodipine Besylate36$189$5
Zolpidem24$162$7
Lorazepam26$154$6
Alendronate16$139$9
Simvastatin19$132$7
Prochlorperazine Maleate16$112$7
Ranitidine18$103$6
Furosemide27$97$4
Allopurinol12$94$8
Metoprolol12$69$6
Metformin11$51$5
Hydrochlorothiazide13$42$3

2013: 40 drugs

Part D drugs prescribed in 2013
Revlimid36$326,604$9,072
Gleevec37$240,345$6,496
Thalomid28$161,612$5,772
Sprycel22$137,622$6,256
Jakafi17$130,810$7,695
Tarceva16$90,830$5,677
Zytiga13$83,709$6,439
Enoxaparin12$35,865$2,989
Procrit12$29,158$2,430
Hydroxyurea84$5,737$68
Lyrica12$3,770$314
Anagrelide12$3,584$299
Fentanyl14$2,959$211
Letrozole70$2,935$42
Valacyclovir23$2,118$92
Tamoxifen Citrate72$1,415$20
Anastrozole23$1,112$48
Morphine Sulfate Er15$622$41
Hydrocodone-Acetaminophen60$614$10
Acyclovir29$495$17
Gabapentin28$469$17
Dexamethasone44$432$10
Ondansetron16$388$24
Synthroid12$388$32
Megestrol Acetate11$337$31
Alendronate30$310$10
Omeprazole31$308$10
Levofloxacin15$273$18
Mirtazapine17$259$15
Oxycodone-Acetaminophen20$250$13
Mupirocin11$236$21
Atorvastatin12$221$18
Warfarin17$203$12
Tamsulosin12$172$14
Lorazepam15$146$10
Furosemide22$103$5
Prednisone17$95$6
Spironolactone11$88$8
Hydrochlorothiazide22$74$3
Clonidine14$57$4

Money from drug and device companies

$271 in 2025

Industry payments by year
202523None$271
202411None$129
202311None$19
202111None$14

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
AstraZeneca Pharmaceuticals LPLynparza$246
2 payments
  • Meals for Lynparza · 2025-12-04 · $121
  • Meals for Lynparza · 2025-07-17 · $125
Astellas Pharma USVyloy$25
1 payment
  • Meals for Vyloy · 2025-04-14 · $25
See all 3 published payments
Every published payment
AstraZeneca Pharmaceuticals LPMeals · 2025-12-04Lynparza$121
AstraZeneca Pharmaceuticals LPMeals · 2025-07-17Lynparza$125
Astellas Pharma USMeals · 2025-04-14Vyloy$25
See earlier years (2024, 2023, 2021)

2024: $129

Payments by company in 2024
AstraZeneca Pharmaceuticals LPLynparza$129
1 payment
  • Meals for Lynparza · 2024-12-18 · $129

2023: $19

Payments by company in 2023
GlaxoSmithKlineOjjaara$19
1 payment
  • Meals for Ojjaara · 2023-10-18 · $19

2021: $14

Payments by company in 2021
Acrotech BiopharmaBeleodaq$14
1 payment
  • Education for Beleodaq · 2021-09-29 · $14

Professional record

NPI
1891870317
Licence
CA G84369California G84369: Current · expires 2028-01-31
Trained
Stanford University School of Medicine, 1996 · 30 years ago
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Medicaid ID
CA 00G843690
Taxonomy
Medical oncology (207RX0202X); Internal medicine (207R00000X)
Mailing address
2589 Samaritan Dr Ste 200, San Jose, CA, 95124
NPI first listed
2006-10-25
NPI last updated
2024-04-17
NPI record certified
2024-04-17

This is when the NPI record was last certified, not a medical board exam.